BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
about
Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.Charting protein complexes, signaling pathways, and networks in the immune system.Cytokines in systemic lupus erythematosusThe infectious etiology of vasculitis.Update on Biologic Therapies for Systemic Lupus Erythematosus.IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies.Influenza virus host response of C57Bl/6 mice treated with TACI-Ig.Individual and epistatic effects of genetic polymorphisms of B-cell co-stimulatory molecules on susceptibility to pemphigus foliaceus.A Novel BLyS Peptibody Down-Regulates B Cell and T Helper Cell Subsets In Vivo and Ameliorates Collagen-Induced Arthritis.Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosusProfiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes
P2860
Q33368623-C12C69DF-0C15-4D3B-8AD2-C96463F4C520Q33373525-C1B6F9F9-A4C9-48FA-924A-782CE035D87EQ33803763-ACCE4FE3-21C5-46C1-BAC4-2727DEF8867FQ34960458-AA811BA0-43B8-4955-AA9C-C17FEC1A8C52Q36453373-4CAF4731-289C-4C56-ABF9-0F631A3E4011Q36659210-21BFDA75-7F67-4516-8127-4CD83DA6E94BQ37610414-6A4C52DD-FC9D-416A-974C-F0A9EA245E56Q38864797-41C4E9C8-6CAA-456C-9272-6C1D2C7D14ACQ39729327-1BA2E4FE-28E2-4AD0-8C68-103974F49865Q42320922-EE64AB9E-94D2-4745-8154-B660D9293F1EQ45416917-226E1640-3FE1-405F-9B54-8001344D9ECBQ47865474-5F70DC12-9220-49B4-937F-186A7B50057BQ52885446-12EAF17D-E6D1-4E88-BC1C-4D72F53081F9Q57078470-1153015B-0012-4E3C-BFB4-794F2A0765D2Q58122908-77A9676C-3607-4FC6-BE32-8C1FA2E9CDE8
P2860
BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
BLyS--an essential survival fa ...... hology and therapeutic target.
@ast
BLyS--an essential survival fa ...... hology and therapeutic target.
@en
type
label
BLyS--an essential survival fa ...... hology and therapeutic target.
@ast
BLyS--an essential survival fa ...... hology and therapeutic target.
@en
prefLabel
BLyS--an essential survival fa ...... hology and therapeutic target.
@ast
BLyS--an essential survival fa ...... hology and therapeutic target.
@en
P1433
P1476
BLyS--an essential survival fa ...... hology and therapeutic target.
@en
P2093
Kevin P Baker
P304
P356
10.1016/J.AUTREV.2004.02.001
P577
2004-07-01T00:00:00Z